Latest Articles

Lipid-Lowering Therapy and Achievement of Lipid Targets ESC and EAS Guidelines

LLTs and Antithrombotic Therapy in PAD

LLTs Exposure Time and Major Vascular Risk Reduction

Possible Challenges Post One Year of ESC/EAS Guidelines

Prognostic impact of achieving LDL cholesterol guidelines

Perceptions and Barriers on the use of PCSK9 inhibitors

LDL-C The Only Causal Risk Factor for ASCVD

Why low-density lipoprotein-cholesterol, the only causal risk factor for atherosclerotic cardiovascular disease, is still overlooked and underestimated.

LDL-C Targets in Patients with Heterozygous Familial Hypercholesterolemia

PCSK9 Inhibitors in Real World Practice